Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 2.677
+0.086 (3.32%)
Nov 11, 2026, 5:35 PM CET
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €509.31 million as of November 11, 2026. It is the 13,639th most valuable company in the world and the 184th biggest in France. Its market cap has decreased by 20.28% in one year.
Market Cap
509.31M
Enterprise Value
598.02M
Revenue
142.94M
Global Rank
Country Rank
#184 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 509.31M, an increase of 414.05%. That is a compound annual growth rate of 8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 509.31M | -20.71% |
| Dec 31, 2025 | 642.32M | 82.94% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.47B |
| MedinCell | 1.07B |
| Inventiva | 793.90M |
| DBV Technologies | 630.29M |
| Genfit | 531.33M |
| Valerio Therapeutics Société anonyme | 237.24M |
| Transgene | 206.78M |
| Innate Pharma | 123.68M |